Reasons to Retain Stryker (SYK) Stock in Your Portfolio Now
- Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform Mako and its broad product portfolio.
- 06/27/2024
|
Stryker joins Atrium Health affiliate IRCAD North America to advance surgical training and education
- PORTAGE, Michigan and CHARLOTTE, North Carolina, USA, June 18, 2024 /PRNewswire/ -- Stryker is bringing its innovative products, platforms and robotic technologies to IRCAD North America (IRCAD NA), a subsidiary of Atrium Health, as part of a multi-year agreement supporting the creation of a cutting-edge experiential education center in Charlotte, North Carolina. IRCAD NA is set to become the cornerstone of the first research building at "The Pearl," a new innovation district currently under construction in the heart of Charlotte.
- 06/18/2024
|
7 Automation Stocks to Propel Your Portfolio to Profits
- Automation stocks can be a tricky subject fundamentally speaking. With advances in artificial intelligence combined with enhanced connectivity – as in the Internet of Things or IoT – machines can end up taking over human jobs.
- 06/17/2024
|
Stryker's (SYK) LIFEPAK 35 to Offer Advanced Monitoring System
- Stryker (SYK) announces the launch of LIFEPAK 35 monitor/defibrillator, which is likely to aid emergency responders to reduce cognitive load during demanding situations by improving workflow.
- 06/05/2024
|
Stryker's (SYK) Acquisition of Artelon Set to Expand Its Market
- Stryker (SYK) announces the signing of the definitive agreement to acquire a privately held company, Artelon, to strengthen its foothold in the soft tissue fixation market.
- 06/04/2024
|
Stryker releases LIFEPAK 35 monitor/defibrillator
- LIFEPAK 35, a clinically advanced monitor/defibrillator, reduces caregiver burden and streamlines workflow.1 PORTAGE, Mich., USA, June 4, 2024 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of LIFEPAK 35 monitor/defibrillator, the latest product in the monitor/defibrillator space, offering advanced technology and built on an intuitive1, modern platform to help advance patient care.
- 06/04/2024
|
Stryker Announces Definitive Agreement to Acquire Artelon, Inc., Offering a Range of Soft Tissue Fixation Solutions for Orthopaedic Surgeons
- KALAMAZOO, Mich.--(BUSINESS WIRE)--Stryker announced the signing of a definitive agreement to acquire all of the issued and outstanding shares of Artelon.
- 06/03/2024
|
Stryker (SYK) to Launch Gamma4 Hip Fracture System in Europe
- Stryker (SYK) announces plan to launch its Gamma4 Hip Fracture Nailing System in Europe. It completes initial surgeries successfully.
- 05/30/2024
|
The 3 Best MedTech Stocks to Buy Now: May 2024
- In a recent deep-dive research report on the state of the MedTech (medical technology) sector, Oppenheimer highlighted the potential of artificial intelligence (AI) in the sector, noting its capacity to save an estimated $200 billion to $300 billion annually through enhanced workflow management. Inspired by these findings, this article explores the three best MedTech stocks to buy now, each poised to capitalize on AI-driven advancements.
- 05/29/2024
|
Stryker (SYK) Issues Safety Notice for Its Total Knee System
- Stryker (SYK) issues urgent field safety notice for the Mako Total Knee systems, the application software of which generated software error codes. The company also shares risk mitigation steps.
- 05/29/2024
|
First European Surgeries Completed Using Stryker's Gamma4 Hip Fracture Nailing System
- AMSTERDAM, Netherlands--(BUSINESS WIRE)--The first surgeries utilizing Stryker's Gamma4 Hip Fracture Nailing System were completed in Europe.
- 05/29/2024
|
HealthTech Heroes: 3 Medical Technology Stocks to Buy Before They Boom
- While the biotechnology sector may receive most of the attention under the broad healthcare umbrella, investors ought to spare some love for medical technology stocks. The enterprises undergirding these securities offer tremendously positive potential for overall patient outcomes.
- 05/28/2024
|
3 Robotics Stocks to Buy Now: May 2024
- Automation continues to be a key driving force of technological innovation in the 21st century. Older industrial sectors have relied on automation for driving efficiencies across the use of various equipment.
- 05/23/2024
|
Inside information: Alan Donze has been appointed as Bioretec's new CEO
- Bioretec Ltd Inside information 20 May 2024 at 6:00 p.m. EEST TAMPERE, Finland, May 20, 2024 /PRNewswire/ -- Bioretec Ltd is pleased to announce that Mr. Alan Donze has been appointed CEO of Bioretec as of today, 20 May 2024. He will start in this position immediately. With a distinguished career spanning the banking and medical device industries, Mr. Donze brings a wealth of experience and expertise to the Bioretec organization. Mr. Donze began his career journey in the banking industry, serving as the Vice President of Commercial Lending and Leveraged Finance for a regional predecessor to Chase bank. He left banking to begin his medical device career as a Regional Sales Representative for Stryker Endoscopy in 1991. Over his 13 years at Stryker, Mr. Donze's responsibilities increased to various senior management positions, including Vice President General Manager of Stryker Endoscopic Service and Vice President General Manager of Stryker Communications, a division he was given the tremendous opportunity to create and build from the ground up. Mr. Donze has also held senior leadership positions for a number of other medical device and technology companies including Smith+Nephew, Bioventus, and Lima Corporate and venture-led startups such as Isotis Orthobiologics, Aerobiotix and Rx.Health. Mr. Donze received his Bachelor of Science in Finance from Louisiana State University. "We are excited to announce the appointment of Alan Donze as our new Chief Executive Officer. With his proven track record of leadership and vision, we are confident that Alan will lead our company to new heights of commercial success. Alan brings with him 30 years of sales and marketing leadership experience in medical devices, where he has demonstrated a deep understanding of market dynamics and a relentless drive for excellence. His strategic insights and passion for Bioretec's mission make him the ideal leader to guide us into the future," says Tomi Numminen, Bioretec's Chairman of the Board. "I am honored to be given the opportunity to lead Bioretec to the next level and deeply appreciate the confidence placed in me by the Board of Directors. Bioretec's groundbreaking work in developing alternatives to traditional metal implants represents a significant advancement in the medical field. Our products have the potential to reduce the need for invasive surgeries and improve patient outcomes, aligning with a critical need within the healthcare community. I am eager to contribute to Bioretec's mission by expanding our efforts to introduce these transformative solutions to the benefit of many more patients. I look forward to the journey ahead and to our continued growth and success," says Alan Donze. Timo Lehtonen, Bioretec's CEO since 2019, will transfer to the position of Chief Technology Officer (CTO) and continue to lead the development of Bioretec's future product pipeline. "It has been a privilege to lead Bioretec since 2019 and support its remarkable growth through interesting, challenging times. I am excited to focus my efforts on advancing the RemeOs™product pipeline. Together with Alan, I am confident we will continue to strengthen our growth and transform bone fracture care. In my forthcoming role as CTO, I will leverage my extensive experience in innovation, product development, and regulatory expertise to support the management team and our skilled personnel. Our goal is to achieve the best possible outcomes in redefining bone fracture treatment and improving patients' quality of life," says Timo Lehtonen. "I would like to thank Timo Lehtonen for his passionate and dedicated leadership as our CEO over the past five years. Under his guidance, Bioretec has grown strongly and strengthened its position as a leading innovator in biodegradable technologies. With its biodegradable metal implants, the company has significantly modernized the surgical treatment of bone fractures, which significantly increases the quality of the lives of the patients. Our mutual and succesful path with Timo continues while he assumes the role of CTO in which role he continues to provide important support for the future development of our product pipeline," says Chairman of the Board Tomi Numminen. Further enquiries Tomi Numminen, Chairman of the Board, tel. +358 40 581 2132 Certified advisor Nordic Certified Adviser AB, +46 70 551 67 29 Information about Bioretec Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of biodegradable orthopedic implants. The company has built unique competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries. Bioretec is developing the new RemeOs™ product line based on a magnesium alloy and hybrid composite, introducing a new generation of strong biodegradable materials for enhanced surgical outcomes. The RemeOs™ implants are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The combination has the potential to make titanium implants redundant and help clinics reach their Value-Based Healthcare targets while focusing on value for patients through efficient healthcare. The first RemeOs™ product market authorization has been received in the U.S. in March 2023, and in Europe, the CE-mark is expected to be received during the second quarter of 2024. Bioretec is positioning itself to enter the addressable USD 7 billion global orthopedic trauma market and become a game changer in surgical bone fracture treatment. Better healing - Better life. www.bioretec.com This information was brought to you by Cision http://news.cision.com https://news.cision.com/bioretec/r/inside-information--alan-donze-has-been-appointed-as-bioretec-s-new-ceo,c3984605 The following files are available for download:
- 05/20/2024
|
Inside information: Alan Donze has been appointed as Bioretec's new CEO
- Bioretec Ltd Inside information 20 May 2024 at 6:00 p.m. EEST TAMPERE, Finland, May 20, 2024 /PRNewswire/ -- Bioretec Ltd is pleased to announce that Mr. Alan Donze has been appointed CEO of Bioretec as of today, 20 May 2024. He will start in this position immediately. With a distinguished career spanning the banking and medical device industries, Mr. Donze brings a wealth of experience and expertise to the Bioretec organization. Mr. Donze began his career journey in the banking industry, serving as the Vice President of Commercial Lending and Leveraged Finance for a regional predecessor to Chase bank. He left banking to begin his medical device career as a Regional Sales Representative for Stryker Endoscopy in 1991. Over his 13 years at Stryker, Mr. Donze's responsibilities increased to various senior management positions, including Vice President General Manager of Stryker Endoscopic Service and Vice President General Manager of Stryker Communications, a division he was given the tremendous opportunity to create and build from the ground up. Mr. Donze has also held senior leadership positions for a number of other medical device and technology companies including Smith+Nephew, Bioventus, and Lima Corporate and venture-led startups such as Isotis Orthobiologics, Aerobiotix and Rx.Health. Mr. Donze received his Bachelor of Science in Finance from Louisiana State University. "We are excited to announce the appointment of Alan Donze as our new Chief Executive Officer. With his proven track record of leadership and vision, we are confident that Alan will lead our company to new heights of commercial success. Alan brings with him 30 years of sales and marketing leadership experience in medical devices, where he has demonstrated a deep understanding of market dynamics and a relentless drive for excellence. His strategic insights and passion for Bioretec's mission make him the ideal leader to guide us into the future," says Tomi Numminen, Bioretec's Chairman of the Board. "I am honored to be given the opportunity to lead Bioretec to the next level and deeply appreciate the confidence placed in me by the Board of Directors. Bioretec's groundbreaking work in developing alternatives to traditional metal implants represents a significant advancement in the medical field. Our products have the potential to reduce the need for invasive surgeries and improve patient outcomes, aligning with a critical need within the healthcare community. I am eager to contribute to Bioretec's mission by expanding our efforts to introduce these transformative solutions to the benefit of many more patients. I look forward to the journey ahead and to our continued growth and success," says Alan Donze. Timo Lehtonen, Bioretec's CEO since 2019, will transfer to the position of Chief Technology Officer (CTO) and continue to lead the development of Bioretec's future product pipeline. "It has been a privilege to lead Bioretec since 2019 and support its remarkable growth through interesting, challenging times. I am excited to focus my efforts on advancing the RemeOs™product pipeline. Together with Alan, I am confident we will continue to strengthen our growth and transform bone fracture care. In my forthcoming role as CTO, I will leverage my extensive experience in innovation, product development, and regulatory expertise to support the management team and our skilled personnel. Our goal is to achieve the best possible outcomes in redefining bone fracture treatment and improving patients' quality of life," says Timo Lehtonen. "I would like to thank Timo Lehtonen for his passionate and dedicated leadership as our CEO over the past five years. Under his guidance, Bioretec has grown strongly and strengthened its position as a leading innovator in biodegradable technologies. With its biodegradable metal implants, the company has significantly modernized the surgical treatment of bone fractures, which significantly increases the quality of the lives of the patients. Our mutual and succesful path with Timo continues while he assumes the role of CTO in which role he continues to provide important support for the future development of our product pipeline," says Chairman of the Board Tomi Numminen. Further enquiries Tomi Numminen, Chairman of the Board, tel. +358 40 581 2132 Certified advisor Nordic Certified Adviser AB, +46 70 551 67 29 Information about Bioretec Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of biodegradable orthopedic implants. The company has built unique competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries. Bioretec is developing the new RemeOs™ product line based on a magnesium alloy and hybrid composite, introducing a new generation of strong biodegradable materials for enhanced surgical outcomes. The RemeOs™ implants are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The combination has the potential to make titanium implants redundant and help clinics reach their Value-Based Healthcare targets while focusing on value for patients through efficient healthcare. The first RemeOs™ product market authorization has been received in the U.S. in March 2023, and in Europe, the CE-mark is expected to be received during the second quarter of 2024. Bioretec is positioning itself to enter the addressable USD 7 billion global orthopedic trauma market and become a game changer in surgical bone fracture treatment. Better healing - Better life. www.bioretec.com This information was brought to you by Cision http://news.cision.com https://news.cision.com/bioretec/r/inside-information--alan-donze-has-been-appointed-as-bioretec-s-new-ceo,c3984605 The following files are available for download:
- 05/20/2024
|
Stryker declares a $0.80 per share quarterly dividend
- Portage, Michigan, May 09, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable July 31, 2024 to shareholders of record at the close of business on June 28, 2024, representing an increase of 6.7% versus the prior year and unchanged from the previous quarter.
- 05/09/2024
|
First Surgeries Using Stryker's Infinity With Adaptis and Everlast Successfully Completed in Europe
- AMSTERDAM--(BUSINESS WIRE)--Stryker announced the completion of the first European surgeries using the Infinity Total Ankle System with Adaptis and Everlast technology.
- 05/07/2024
|
Stryker's (SYK) Q1 Earnings Beat Estimates, Guidance Raised
- Stryker's (SYK) first-quarter earnings reflect strong performance across its segments and geographies. Operating and gross margins increase, with earnings and revenues beating their respective estimates.
- 05/01/2024
|
Stryker Corporation (SYK) Q1 2024 Earnings Call Transcript
- Start Time: 16:30 January 1, 0000 5:28 PM ET Stryker Corporation (NYSE:SYK ) Q1 2024 Earnings Conference Call April 30, 2024, 16:30 PM ET Company Participants Kevin Lobo - Chair and CEO Glenn Boehnlein - VP and CFO Jason Beach - VP, Finance and IR Conference Call Participants Robert Marcus - JPMorgan Lawrence Biegelsen - Wells Fargo Securities Ryan Zimmerman - BTIG Joanne Wuensch - Citibank Pito Chickering - Deutsche Bank Shagun Singh Chadha - RBC Capital Vijay Kumar - Evercore Travis Steed - Bank of America Matthew O'Brien - Piper Sandler Matt Miksic - Barclays Danielle Antalffy - UBS Matt Taylor - Jefferies Caitlin Cronin - Canaccord Sam Brodovsky - Truist Joshua Jennings - Cowen Andrew Ranieri - Morgan Stanley Operator Welcome to the First Quarter 2024 Stryker Earnings Call. My name is Christine, and I'm your operator for today's call.
- 04/30/2024
|
Stryker lifts 2024 profit forecast on strong demand for medical devices, implants
- Stryker Corp lifted its full-year profit forecast on Tuesday, owing to resilient demand for the company's medical devices and implants.
- 04/30/2024
|
Here's What Key Metrics Tell Us About Stryker (SYK) Q1 Earnings
- The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 04/30/2024
|
Stryker (SYK) Beats Q1 Earnings and Revenue Estimates
- Stryker (SYK) came out with quarterly earnings of $2.50 per share, beating the Zacks Consensus Estimate of $2.35 per share. This compares to earnings of $2.14 per share a year ago.
- 04/30/2024
|
Stryker reports first quarter 2024 operating results
- Portage, Michigan, April 30, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2024:
- 04/30/2024
|
Seeking Clues to Stryker (SYK) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
- Evaluate the expected performance of Stryker (SYK) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- 04/25/2024
|
SYK vs ZBH: Which Stock Looks More Promising Ahead of Q1 Earnings?
- SYK and ZBH are expected to have witnessed strong procedural volume growth across the global market in the first quarter.
- 04/24/2024
|
Ongoing Procedural Growth May Aid Stryker's (SYK) Q1 Earnings
- Stryker's (SYK) first-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
- 04/24/2024
|
Medical AI Could Be Your Ticket to Riches: 3 Stocks to Buy
- While artificial intelligence may be useful for a variety of purposes – including asking silly questions we're afraid to pose in real life – the ultimate end game for digital intelligence could be to advance the human condition, which brings us to medical AI stocks. When conducted in a controlled environment, AI can help accelerate productivity.
- 04/23/2024
|
Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/23/2024
|
3 Robotics Stocks to Turn $1000 into $1 Million: April 2024
- Robotics and related technologies, such as workflow automation products, cloud services, and generative AI technology, have captivated the investing community. They have assisted in leading the overall market higher over this past year especially.
- 04/18/2024
|
Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales
- ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice President, Sales. In this role, Rooney will lead U.S. market growth and sales efforts. Rooney comes to Spineology with extensive spine sales experience, having served in Medical Device fields related to spinal implants and navigation for nearly 20 years. “The addition of Emory adds even further con.
- 04/04/2024
|
5 Medical Product Stocks to Buy Amid Industry Challenges
- Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. SYK, RMD, ZBH, PODD and LNTH are well-poised to gain from the favorable factors.
- 04/02/2024
|
Stryker to announce financial results for its first quarter of fiscal year 2024
- Portage, Michigan, April 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2024 on Tuesday, April 30, 2024. A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company's first quarter of fiscal year 2024, that ended March 31, 2024.
- 04/01/2024
|
Is Stryker (SYK) Stock Outpacing Its Medical Peers This Year?
- Here is how Stryker (SYK) and Athira Pharma, Inc. (ATHA) have performed compared to their sector so far this year.
- 03/29/2024
|
Stryker's (SYK) Latest Launch to Streamline Procedural Workflows
- Stryker's (SYK) latest addition to its Gamma legacy is expected to streamline workflows and enhance usability.
- 03/27/2024
|
Stryker announces Annual Meeting of Shareholders
- Portage, Michigan, March 26, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2024 Annual Meeting of Shareholders is scheduled as follows:
- 03/26/2024
|
Stryker (SYK) Acquires SERF SAS to Aid Its Orthopedic Segment
- Stryker (SYK) completes its acquisition of SERF SAS, a France-based joint replacement company. With this acquisition, Stryker aims to boost its orthopedic division in the European region.
- 03/22/2024
|
Reasons to Add Stryker (SYK) Stock in Your Portfolio Now
- Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.
- 03/21/2024
|
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
- There are some robotic surgery stocks for investors to buy in March this year. The growth of robotic-assisted surgery has been driven by its potential benefits, such as smaller incisions, reduced pain and scarring, quicker recovery times, and improved clinical outcomes.
- 03/13/2024
|
Stryker (SYK) Completes First Arthroplasty Surgery in Europe
- Stryker (SYK) completes its first shoulder arthroplasty surgery in Europe using its Blueprint Mixed Reality Guidance system, which aims to benefit shoulder arthroplasty surgeons.
- 03/06/2024
|
HAE or SYK: Which Is the Better Value Stock Right Now?
- Investors with an interest in Medical - Products stocks have likely encountered both Haemonetics (HAE) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?
- 02/27/2024
|
Stock Picks For Our Model Portfolio In A Broken Market (Technical Analysis)
- Stock Picks For Our Model Portfolio In A Broken Market (Technical Analysis)
- 02/20/2024
|
Stryker: Rerating Higher
- Stryker is a leading medical technology company with a diversified product portfolio that targets orthopedic surgery amongst other end markets. Stryker is currently reaping the rewards of a decade of heavy investment (R&D and M&A), with growth picking up and margins set to follow. Stryker's bright prospects are gradually being priced into the stock, with the company's revenue multiple expanding over the past decade.
- 02/07/2024
|
Stryker: A Dividend Growth Powerhouse I'd Like To Own
- Superb quality often comes with a price, which is a lesson that I learned with Stryker. The medtech giant's net sales and adjusted diluted EPS both climbed at double-digit clips in Q4. Stryker earns a BBB+ credit rating from S&P on a stable outlook.
- 02/02/2024
|
Stryker CEO Kevin Lobo on M&A goals in 2024
- Stryker CEO Kevin Lobo joins 'Money Movers' to discuss the company's quarterly earnings results, what offensive M&A could look like for Stryker, and what's driving the company's organic growth.
- 01/31/2024
|
Stryker's (SYK) Q4 Earnings & Revenues Surpass Estimates
- Stryker's (SYK) fourth-quarter earnings reflect strong performance across its segments and geographies. Operating and gross margins increased, with earnings and revenues beating estimates.
- 01/31/2024
|
4 med tech stocks with improving prognosis for 2024
- Med tech stocks have been a mixed bag of results the last two years, with most moving within established trading ranges. The impact of COVID and its effect on procedure volumes were slow to dissipate, and the growth outlook was uncertain, leaving the market for their stock without a solid catalyst to drive it despite many trading at value levels and paying healthy dividends.
- 01/31/2024
|
Stryker Corporation (SYK) Q4 2023 Earnings Call Transcript
- Stryker Corporation (SYK) Q4 2023 Earnings Call Transcript
- 01/30/2024
|
Stryker (SYK) Reports Q4 Earnings: What Key Metrics Have to Say
- The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 01/30/2024
|
Stryker (SYK) Surpasses Q4 Earnings and Revenue Estimates
- Stryker (SYK) came out with quarterly earnings of $3.46 per share, beating the Zacks Consensus Estimate of $3.27 per share. This compares to earnings of $3 per share a year ago.
- 01/30/2024
|
Stryker forecasts strong 2024 as uptick in surgeries lift demand for devices
- Stryker Corp forecast 2024 profit above Wall Street estimates on Tuesday, banking on a post-pandemic pick-up in volume for certain surgical procedures at hospitals to drive sales for its medical and surgical devices.
- 01/30/2024
|
Countdown to Stryker (SYK) Q4 Earnings: Wall Street Forecasts for Key Metrics
- Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Stryker (SYK), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.
- 01/25/2024
|
3 Robotics Stocks to Buy and Hold Forever: January 2024
- The robotics sector is on the brink of an extraordinary boom, with MarketsandMarkets projecting its value to skyrocket from $17.0 billion in 2023 to $32.5 billion by 2028. This steep ascent is just the beginning.
- 01/24/2024
|
Final Trades: Abbvie, Stryker, Crown Castle, Marathon Petroleum
- Jim Lebenthal, chief equity strategist at Cerity Partners, Jenny Harrington, Gilman Hill Asset Management CEO, Joe Terranova, senior managing director at Virtus Investment Partners, and Brenda Vingiello, Sand Hill Global Advisors CIO, give their top picks to watch for the second half.
- 01/12/2024
|
Health care stocks are back in favor and these 3 names could lead the rally, according to the charts
- Here are three stocks in the health care sector that could provide further upside potential based on their improving technical characteristics.
- 01/11/2024
|
The 3 Best Robotics Stocks to Buy in January 2024
- One very promising and innovative area of technology is robotics. Finding the best robotics stocks is not only a stroke of luck for savvy investors looking to exploit this highly-growing industry.
- 01/08/2024
|
Generative AI Reshapes Healthcare: 3 Stocks in Limelight
- Stocks like Medtronic (MDT), Stryker (SYK) and NVIDIA (NVDA) are likely to benefit from the rising prospects of Generative AI in healthcare.
- 01/05/2024
|
Stryker to announce financial results for its fourth quarter and full year 2023
- Portage, Michigan, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for fourth quarter and full year 2023 on Tuesday, January 30, 2024. A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company's fourth quarter and full year 2023, that ended December 31, 2023.
- 01/05/2024
|
Reasons to Retain Stryker (SYK) Stock in Your Portfolio Now
- Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.
- 01/04/2024
|
HAE or SYK: Which Is the Better Value Stock Right Now?
- Investors interested in Medical - Products stocks are likely familiar with Haemonetics (HAE) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
- 01/03/2024
|
Will Stryker (SYK) Beat Estimates Again in Its Next Earnings Report?
- Stryker (SYK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/02/2024
|
HAE vs. SYK: Which Stock Is the Better Value Option?
- Investors with an interest in Medical - Products stocks have likely encountered both Haemonetics (HAE) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?
- 12/18/2023
|
Reasons to Retain Stryker (SYK) Stock in Your Portfolio Now
- Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.
- 12/04/2023
|
Why Stryker Is An Awesome Healthcare Compounder
- Stryker boasts a 13.7% annual return, consistent dividends, and innovation-driven market dominance. Stryker's focus on Orthopaedics and Spine, coupled with a resilient financial position and strategic acquisitions, positions it for continued success. Despite a premium valuation, Stryker's strong balance sheet, 30-year dividend growth history, and low payout ratio make it an appealing long-term investment.
- 11/30/2023
|
Stryker Corporation (SYK) 6th Annual Evercore ISI HealthCONx Conference (Transcript)
- Stryker Corporation (NYSE:SYK ) 6th Annual Evercore ISI HealthCONx Conference November 29, 2023 1:20 PM ET Company Participants Glenn Boehnlein - CFO Jason Beach - Head, IR Conference Call Participants Vijay Kumar - Evercore ISI Vijay Kumar Stryker this afternoon. We have Glenn Boehnlein, CFO; and Jason Beach, who heads Investor Relations.
- 11/29/2023
|
HAE or SYK: Which Is the Better Value Stock Right Now?
- Investors looking for stocks in the Medical - Products sector might want to consider either Haemonetics (HAE) or Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?
- 11/15/2023
|
Bulgarian parliament okays $1.5 billion purchase of Stryker fighting vehicles from US
- The Bulgarian parliament on Thursday approved a $1.5 billion purchase of Stryker fighting vehicles from the United States to modernise the country's army and bring it in line with NATO standards, the BTA news agency reported.
- 11/09/2023
|
Here's What Key Metrics Tell Us About Stryker (SYK) Q3 Earnings
- Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 11/03/2023
|
Stryker (SYK) Q3 Earnings Beat on Strong Segmental Result
- Stryker's (SYK) third-quarter earnings reflect strong performance across its segments and geographies. However, unfavorable currency movement hurts sales growth, and rising costs affect margins.
- 11/03/2023
|
Stryker tightens profit forecast on steady demand for its medical devices
- Stryker Corp on Thursday raised the lower end of its full-year profit forecast as the medtech company sees steady demand for its medical and surgical devices from a post-pandemic pick-up in volumes of surgical procedures at hospitals.
- 11/02/2023
|
Stay Ahead of the Game With Stryker (SYK) Q3 Earnings: Wall Street's Insights on Key Metrics
- Evaluate the expected performance of Stryker (SYK) for the quarter ended September 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- 11/01/2023
|
Stryker (SYK) to Report Q3 Earnings: Is a Beat in Store?
- Stryker's (SYK) third-quarter 2023 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued hurting margins.
- 10/31/2023
|
BAX vs. SYK: Which Stock Is the Better Value Option?
- Investors looking for stocks in the Medical - Products sector might want to consider either Baxter International (BAX) or Stryker (SYK). But which of these two stocks is more attractive to value investors?
- 10/30/2023
|
Stryker (SYK) Reports Next Week: Wall Street Expects Earnings Growth
- Stryker (SYK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/26/2023
|
Will Stryker (SYK) Beat Estimates Again in Its Next Earnings Report?
- Stryker (SYK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/24/2023
|
The Value Deepens for Medtech Stocks: Reversal Imminent
- Results from Johnson & Johnson NYSE: JNJ and Abbott Laboratories NYSE: ABT foreshadow good news for MedTech investors. Both companies outperformed on the top and bottom lines, driven by broad strength in their MedTech units.
- 10/23/2023
|
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off
- AbbVie is a high-yield dividend stock that packs a punch. Stryker is a well-rounded business.
- 10/17/2023
|
Stryker: Don't Buy This Dividend Champion (Yet)
- Stryker's dividend is covered by both adjusted diluted EPS and free cash flow, which should bode well for future dividend growth. The company's dedication to research and development supports its strong operating fundamentals. Stryker's interest coverage was nearly 14 in the first half of 2023, which explains why it enjoys a BBB+ credit rating from S&P.
- 10/13/2023
|
5 Medical Product Stocks to Buy Amid Industry Recovery
- Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. SYK, BSX, ZBH, PODD and HAE are well-poised to gain from the favorable factors.
- 10/12/2023
|
What other industries could weight loss drugs disrupt?
- Jared Holz, Mizuho health care sector strategist, joins the ‘Fast Money' traders to discuss Novo Nordisj's kidney trial outcomes and the impact of weight loss drugs on the health care sector.
- 10/11/2023
|
To Dodge Russian Missiles, Ukraine's U.S.-Made Stryker Fighting Vehicles Dodge And Weave. It's A Tactic From 1973.
- A Sagger drill still works at times, and especially in a vehicle as maneuverable as a Stryker is.
- 10/07/2023
|
Both Wall Street and food companies are overreacting to weight-loss drugs, say Herb Greenberg
- Hosted by Brian Sullivan, “Last Call” is a fast-paced, entertaining business show that explores the intersection of money, culture and policy.
- 10/05/2023
|
Reasons to Add Stryker (SYK) Stock to Your Portfolio Now
- Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the stock.
- 10/04/2023
|
Stryker to announce financial results for its third quarter of fiscal year 2023
- Kalamazoo, Michigan, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for third quarter of fiscal year 2023 on Thursday, November 2, 2023. A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company's third quarter of fiscal year 2023, that ended September 30, 2023.
- 10/02/2023
|
HAE vs. SYK: Which Stock Is the Better Value Option?
- Investors with an interest in Medical - Products stocks have likely encountered both Haemonetics (HAE) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
- 09/25/2023
|
Stryker's (SYK) New Camera Platform to Improve Surgery Outcomes
- Stryker's (SYK) latest camera platform is likely to enhance the surgical experience across specialties.
- 09/15/2023
|
Stryker (SYK) Gets FDA 501k Clearance for Pangea Trauma Systems
- Stryker's (SYK) Pangea systems will boost the company's Trauma business unit following a complete launch. SYK plans to present the new system at the Annual Orthopaedic Trauma Association meeting.
- 09/13/2023
|
Stryker Corporation (SYK) Wells Fargo Securities Healthcare Conference (Transcript)
- Stryker Corporation (NYSE:SYK ) Wells Fargo Securities Healthcare Conference Call September 7, 2023 3:00 PM ET Company Participants Glenn Boehnlein - CFO Jason Beach - VP, IR Conference Call Participants Larry Biegelsen - Wells Fargo Larry Biegelsen I'm Larry Biegelsen, the medical device analyst at Wells Fargo and it's my pleasure to host this session with Stryker. From the company, we have Glenn Boehnlein, the CFO; and Jason Beach, the Vice President of Investor Relations.
- 09/07/2023
|
Stryker upgraded to ‘Buy' on 2024 upside potential
- Analysts at Bank of America have upgraded their rating on medical technologies company Stryker Corporation (NYSE:SYK) to ‘Buy' on their belief it is likely to be a top-tier performer in 2024. They also increased their price target on the Kalamazoo, Michigan-based company from US$310 to US$315.
- 09/05/2023
|
Here are 19 stocks Jim Cramer is watching, including Chipotle, LULU and Airbnb
- Here are some of the tickers on my radar for Tuesday, Sept. 5, taken directly from my reporter's notebook.
- 09/05/2023
|
Reasons to Add Stryker (SYK) Stock to Your Portfolio Now
- Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the stock.
- 09/04/2023
|
A Significant Reversal is in Sight for These 5 Med Tech Companies
- Med tech has been on the skids for no fault of its own. It's not the industry's fault that price action was driven to a frothy bubble by COVID-inspired trading outlooks or that the market has normalized.
- 08/30/2023
|
HAE vs. SYK: Which Stock Is the Better Value Option?
- Investors looking for stocks in the Medical - Products sector might want to consider either Haemonetics (HAE) or Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?
- 08/22/2023
|
Final Trades: NextEra Energy, Stryker & Zimmer Holdings
- The "Halftime Report" traders give their top picks to watch for the second half.
- 08/22/2023
|
Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology
- Stryker's robotic arm technology for knee replacement surgeries positions them as a leader in orthopedic surgeries. The recovery of procedure volumes post-Covid has already contributed to Stryker's organic growth rate. Stryker's Mako robotic technology is a key growth driver and offers a unique value proposition in the market.
- 08/22/2023
|
Is This MedTech Giant a Buy for Dividend Investors?
- Stryker's net sales and earnings climbed in the second quarter. The company's seemingly modest payout could have many more years of growth ahead.
- 08/09/2023
|
Stryker (SYK) Reports Q2 Earnings: What Key Metrics Have to Say
- Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 08/04/2023
|
Is Stryker Corp (SYK) Fairly Valued? An In-depth Analysis
- Today, Stryker Corp ( SYK , Financial) experienced a daily change of 3.27%, with an Earnings Per Share (EPS) of 6.87. The question on the minds of many investors is whether the stock is fairly valued.
- 08/04/2023
|
Final Trades: Boeing, Stryker & Wynn
- The "Halftime Report" traders give their top picks to watch for the second half.
- 08/04/2023
|
Stryker CEO: We're in the midst of 'supercycle of innovation' across our capital equipment business
- Kevin Lobo, Stryker CEO, joins 'Squawk on the Street' to discuss the key factors for Stryker's growth, how long the backlog of procedures will last for the company, and Stryker's next catalyst for growth.
- 08/04/2023
|
Stryker (SYK) Q2 Earnings Beat Estimates, Volume Improves
- Stryker's (SYK) second-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurts sales growth and rising costs affect margins.
- 08/04/2023
|
Stryker (SYK) Q2 Earnings and Revenues Beat Estimates
- Stryker (SYK) came out with quarterly earnings of $2.54 per share, beating the Zacks Consensus Estimate of $2.38 per share. This compares to earnings of $2.25 per share a year ago.
- 08/03/2023
|
Stryker lifts annual profit forecast as demand for its devices picks up
- Stryker raised its annual profit forecast on Thursday as the medtech company sees strong demand for its medical and surgical devices, aided by a post-pandemic pickup in surgical procedure volumes at hospitals.
- 08/03/2023
|
4 Medical Product Stocks to Buy Amid Recovering Prospects
- Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. ABT, SYK, ZBH and HAE are well poised to gain from the favorable factors.
- 07/31/2023
|
HAE or SYK: Which Is the Better Value Stock Right Now?
- Investors interested in stocks from the Medical - Products sector have probably already heard of Haemonetics (HAE) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?
- 07/19/2023
|
Here's Why You Should Add Stryker (SYK) Stock to Your Portfolio
- Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the stock.
- 07/06/2023
|
Bullish Action: Chipotle, Visa, Stryker Break Through Resistance
- Chipotle Mexican Grill Inc. NYSE: CMG, Visa Inc. NYSE: V and Stryker Corp. NYSE: SYK may not, at first glance, seem like they have much in common. However, they're part of an elite group: All are S&P 500 components that are in buy range after recently breaking out of chart bases.
- 07/06/2023
|
Stryker (SYK) Stock Hits 52-Week High: More Room to Grow?
- Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the stock.
- 07/03/2023
|
Stryker to announce financial results for its second quarter of fiscal year 2023
- Kalamazoo, Michigan, June 30, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for second quarter of fiscal year 2023 on Thursday, August 3, 2023. A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company's second quarter of fiscal year 2023, which ends on June 30, 2023.
- 06/30/2023
|
Elective Surgeries Are On the Rise: 3 Stocks That Can Benefit From This Trend
- The healthcare industry is facing pent-up demand for surgeries. Health insurers may struggle with some additional costs as a result.
- 06/22/2023
|
HLN vs. SYK: Which Stock Should Value Investors Buy Now?
- Investors interested in stocks from the Medical - Products sector have probably already heard of Haleon PLC Sponsored ADR (HLN) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?
- 06/21/2023
|
This Healthcare Stock Is Sending More Cash to Its Shareholders: Should You Buy It?
- Stryker saw both net sales and profits grow in the first quarter. The medical device maker's dividend is easily covered by earnings.
- 06/21/2023
|
2 Healthcare Stocks That Could Help Set You Up for Life
- Stryker and Humana operate as leaders in their respective industries. The payouts of the two companies are each well-covered.
- 06/19/2023
|
Stryker (SYK) Moves 4.2% Higher: Will This Strength Last?
- Stryker (SYK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- 06/15/2023
|
HLN or SYK: Which Is the Better Value Stock Right Now?
- Investors with an interest in Medical - Products stocks have likely encountered both Haleon PLC Sponsored ADR (HLN) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
- 06/05/2023
|
Should You Pick Stryker Stock Over BAX For Better Returns?
- There is more to the comparison, and in the sections below, we discuss why we believe that SYK will offer better returns than BAX in the next three years.
- 06/02/2023
|
Why Is Stryker (SYK) Down 7.6% Since Last Earnings Report?
- Stryker (SYK) reported earnings 30 days ago. What's next for the stock?
- 05/31/2023
|
Stryker's (SYK) Q Guidance Successful in First Surgery
- Stryker (SYK) successfully completes first surgical case using its Q Guidance system with Cranial Guidance software. An Early Product Surveillance is underway for the combined technology.
- 05/31/2023
|
Here's Why You Should Retain Stryker (SYK) Stock for Now
- Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the stock.
- 05/26/2023
|
3 Healthcare Trends to Ride for Longevity
- Because of their longevity, predictability, and stability, healthcare trends can persist for years. The companies covered today are fundamentally and technically robust stocks currently taking advantage of these trends.
- 05/22/2023
|
HLN or SYK: Which Is the Better Value Stock Right Now?
- Investors interested in stocks from the Medical - Products sector have probably already heard of Haleon PLC Sponsored ADR (HLN) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?
- 05/18/2023
|
Which Is the Safer Dividend Stock: Stryker or Medtronic?
- Stryker and Medtronic are two of the biggest names in the medical device industry. Stryker is growing steadily, and its recent headwinds are clearing up.
- 05/12/2023
|
16 Stocks Run Circles Around Warren Buffett Over The Long Haul
- Warren Buffett held court again at Berkshire Hathaway's shareholder meeting. But his company could learn from some other S&P 500 companies.
- 05/09/2023
|
Got $5,000? Buy These 2 Stalwart Stocks and Hold Them Forever
- Stalwarts are companies that have stood the test of time without trouble. Thermo Fisher's recent headwinds should have little impact on its long-term outlook.
- 05/03/2023
|
BAX vs. SYK: Which Stock Should Value Investors Buy Now?
- Investors interested in stocks from the Medical - Products sector have probably already heard of Baxter International (BAX) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
- 05/02/2023
|
Stryker (SYK) Q1 Earnings Beat Estimates, Volume Improves
- Stryker's (SYK) first-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurts sales growth and rising costs affect margins.
- 05/02/2023
|
Stryker Corporation (SYK) Q1 2023 Earnings Call Transcript
- Stryker Corporation (NYSE:SYK ) Q1 2023 Earnings Conference Call May 1, 2023 4:30 PM ET Company Participants Kevin Lobo - Chair and Chief Executive Officer Jason Beach - Vice President, Investor Relations Glenn Boehnlein - Vice President, Chief Financial Officer Conference Call Participants Lawrence Biegelsen - Wells Fargo Securities Robert Marcus - JPMorgan Joanne Wuensch - Citibank Vijay Kumar - Evercore ISI Matthew O'Brien - Piper Sandler Ryan Zimmerman - BTIG Eric Anderson - TD Cowen Matt Miksic - Barclays Travis Steed - Bank of America Steven Lichtman - Oppenheimer & Company Rick Wise - Stifel Matthew Mishan - KeyBanc Capital Markets Imron Zafar - Deutsche Bank Richard Newitter - Truist Securities Danielle Antalffy - UBS Jeffrey Johnson - Baird Kyle Rose - Canaccord Operator Good day and welcome to the First Quarter 2023 Stryker Earnings Call. My name is Todd and I'll be your operator for today's call.
- 05/01/2023
|
Stryker (SYK) Tops Q1 Earnings and Revenue Estimates
- Stryker (SYK) came out with quarterly earnings of $2.14 per share, beating the Zacks Consensus Estimate of $2 per share. This compares to earnings of $1.97 per share a year ago.
- 05/01/2023
|
3 Medical Device Stocks Outpacing the Healthcare Industry This Year
- Medtronic has raised its dividend for 45 consecutive years. Edwards Lifesciences had a strong first quarter and upgraded 2023 guidance.
- 05/01/2023
|
These 3 Stocks Might Be Getting a Little Too Expensive
- Shares of candy maker Hershey have gained for a decade at a double-digit percentage rate. Stryker is a diversified healthcare specialist with a promising future.
- 04/30/2023
|
Stryker: Consistently Innovative With Steady Profits And Dividends
- Stryker operates in the medical sector and is engaged in the innovation and sale of medical equipment internationally. SYK has new offerings that partially contributed to its revenues.
- 04/29/2023
|
Earn Double-Digit Income With Options (May 2023)
- We explain why selling cash-covered puts and covered calls are relatively safe choices for earning a high income. We will discuss how to formulate an options income strategy that's sustainable and repeatable.
- 04/29/2023
|
3 Reasons To Consider Buying Stryker Corporation
- Stryker Corporation's innovative surgical solutions position the company to capitalize on the growing demand for joint replacement technology.
- 04/27/2023
|
Healthcare Innovation Drives Medical Device Makers To New Highs
- The healthcare sector has been looking fit in the past month, with medical products makers Stryker Corp. (NYSE: SYK) and Boston Scientific Corp. (NYSE: BSX) rallying to all-time highs, while sector peer DexCom Inc. (NASDAQ: DXCM) is forming a constructive base.
- 04/17/2023
|
HAE vs. SYK: Which Stock Is the Better Value Option?
- Investors with an interest in Medical - Products stocks have likely encountered both Haemonetics (HAE) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
- 04/14/2023
|
Stryker (SYK) is a Great Momentum Stock: Should You Buy?
- Does Stryker (SYK) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 04/11/2023
|
2 Top Stocks to Buy in April and Hold Forever
- Bristol Myers Squibb and Stryker are both developing life-changing products for patients. The two companies each pay growing dividends to shareholders.
- 04/08/2023
|
Here's Why You Should Add Stryker (SYK) Stock to Your Portfolio
- Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the company.
- 04/06/2023
|
Stryker to announce financial results for its first quarter of fiscal year 2023
- Kalamazoo, Michigan, March 30, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2023 on Monday, May 1, 2023. A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company's first quarter of fiscal year 2023, which ends on Friday, March 31, 2023.
- 03/30/2023
|
Investment in procedural medical devices is safer for valuation, says E Squared's Les Funtleyder
- Les Funtleyder, portfolio manager for E Squared Capital Management, joins 'The Exchange' to discuss big cap pharma's Q1 performance, the dollar weakness contributing to biotech gains, and investment opportunities in the pharma space.
- 03/30/2023
|
Earn Double-Digit Income With Options (April 2023)
- We explain why selling cash-covered puts and covered calls are relatively safe choices for earning a high income. We will discuss how to formulate an options income strategy that's sustainable and repeatable.
- 03/27/2023
|
MedTech Bigwigs in Spotlight as AI Revolutionizes Healthcare
- MedTech player like Medtronic (MDT) are integrating artificial intelligence (AI) capabilities to aid therapeutic and diagnostic applications.
- 03/24/2023
|
HAE vs. SYK: Which Stock Should Value Investors Buy Now?
- HAE vs. SYK: Which Stock Is the Better Value Option?
- 03/24/2023
|
Top Wall Street analysts pick these five stocks for the long term
- TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, including BJ's & CrowdStrike
- 03/19/2023
|
3 Dividend Champions for Long-Term Income
- Income investors value reliability and consistency, as well as high dividend yields. Some stocks provide a combination of these factors, such as the Dividend Champions — stocks that have raised their payouts for at least 25 years in a row.
- 03/16/2023
|
Are These Medical Device Makers Getting Ready To Rally?
- Large-cap medical device maker Stryker Corp. (NYSE: SYK) is consolidating along its 50-day moving average, a bullish sign as the stock takes a breather after a run-up that began last year.
- 03/10/2023
|
ESLOY vs. SYK: Which Stock Is the Better Value Option?
- ESLOY vs. SYK: Which Stock Is the Better Value Option?
- 03/08/2023
|
Navigating Volatility: 3 Stocks Worthy of Consideration
- Powell believes returning to bigger rate hikes could be necessary if data suggests the U.S. economy is heating up again. Is this the correct path to take?
- 03/07/2023
|
Here's Why You Should Add Stryker (SYK) Stock to Your Portfolio
- Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on it.
- 03/06/2023
|
Should Investors Buy This Dividend Growth Stock?
- This medical devices company is already up in 2023. Should you buy it?
- 02/12/2023
|
3 Medical Products Stocks Navigating Industry Challenges
- Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. SYK, ZBH and HAE are well-poised to gain from the favorable factors.
- 02/09/2023
|
My Dividend Stock Portfolio: New January Record - 100 Holdings With 26 Buys
- Inflation and (expected) actions by the Federal Reserve continue to dominate market movements. Markets have started the new year with very solid gains following expectations about a more dovish Federal Reserve and a solid earnings season.
- 02/09/2023
|
What Makes Stryker (SYK) a New Buy Stock
- Stryker (SYK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 02/03/2023
|
US Markets Rally Back on Powell Comments
- U.S. stock markets started Feb. 1 with declines on news of the Fed's latest rate hike but ended the day higher following comments from the Fed chair.
- 02/01/2023
|
Stryker Corporation (SYK) Q4 2022 Earnings Call Transcript
- Stryker Corporation (NYSE:SYK ) Q4 2022 Earnings Conference Call January 31, 2023 4:30 PM ET Company Participants Kevin Lobo - Chair and CEO Glenn Boehnlein - Chief Financial Officer Jason Beach - Vice President, Investor Relations Conference Call Participants Robbie Marcus - JPMorgan Matthew O'Brien - Piper Sandler Vijay Kumar - Evercore Shagun Singh - RBC Ryan Zimmerman - BTIG Vik Chopra - Wells Fargo Matt Miksic - Barclays Pito Chickering - Deutsche Bank Steven Lichtman - Oppenheimer Drew Ranieri - Morgan Stanley Michael Matson - Needham & Company Joanne Wuensch - Citi Eric Anderson - Cowen Eric Fleming - Raymond James Operator Welcome to the Fourth Quarter and Full Year 2022 Stryker Earnings Call. My name is Tanya, and I will be your operator for today's call.
- 01/31/2023
|
Stryker (SYK) Q4 Earnings and Revenues Top Estimates
- Stryker (SYK) delivered earnings and revenue surprises of 5.63% and 5.13%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 01/31/2023
|
Final Trades: Stryker, DaVita, Biotech and more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 01/30/2023
|
Why Earnings Season Could Be Great for Stryker (SYK)
- Stryker (SYK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 01/30/2023
|
Eaton Vance Worldwide Health Sciences Fund Adds 3 Stocks to Portfolio
- The Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) disclosed its equity portfolio for the fourth quarter of 2022 earlier this week.
- 01/27/2023
|
The Ukrainian Army's Speedy, Lightly-Armed Stryker Vehicles Are Best At Fighting In Cities
- Stryker brigades really are just infantry brigades—but with big, sophisticated armored personnel carriers.
- 01/20/2023
|
Stryker: Excellent Recent And Continuing Performance
- Stryker is a major medical device company that continues to flesh out its business by targeted acquisitions which, because of its approach, have a strong history of success. The acquisition of Vocera Communications in early 2022 is a clear example of how Stryker makes big changes by acquiring leaders in emerging areas.
- 01/09/2023
|
Here's Why You Should Retain Stryker (SYK) Stock for Now
- Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on it.
- 01/05/2023
|
Stryker to host conference call on January 31, 2023
- Kalamazoo, Michigan, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, January 31, 2023 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending December 31, 2022 and provide an operational update. Final operating results for the quarter will be released at 4:05 p.m. that day.
- 12/28/2022
|
25 Upcoming Dividend Increases To Finish 2022
- All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 8% and a median increase of 5.4%.
- 12/22/2022
|
Final Trades: Stryker, VeriSign, Ardagh Metal & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 12/21/2022
|
Stryker's (SYK) Citrefix to Boost Foot and Ankle Surgeries
- Stryker's (SYK) newly-launched Citrefix will help customers avoid chronic inflammation using Citregen. Its pull-out strength is greatly increased compared to other suture anchors.
- 12/16/2022
|
Paccar, Deere, and 10 More Companies That Raised Their Stock Dividends
- Southwest Airlines also said it will resume paying a dividend.
- 12/10/2022
|
Final Trades: Stryker, Southwest Gas, Freeport-McMoRan & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 12/08/2022
|
Is This Dividend Growth Stock a Buy?
- The medical devices giant has outperformed the S&P 500 index so far in 2022.
- 12/07/2022
|
Why Stryker Has Greatly Outperformed Its Sector
- The health care sector has been the worst place to invest over the last year, with the sector down more than 52% over the last 12 months. Granted, a large part of this has been due to unprofitable biotech startups that went public at sky-high prices and then tanked, but even the big pharma companies haven't been doing too hot for the most part.
- 12/05/2022
|
Stryker Corporation. (SYK) 5th Annual Evercore ISI HealthCONx Conference 2022 (Transcript)
- Stryker Corporation. (NYSE:SYK ) 5th Annual Evercore ISI HealthCONx Conference 2022 December 1, 2022 8:50 AM ET Company Participants Kevin Lobo - Chief Executive Officer Jason Beach - Vice President, Investor Relations Lara Mordoh - Senior Director, Investor Relations Conference Call Participants Vijay Kumar - Evercore ISI Vijay Kumar Great.
- 12/01/2022
|
Here's Why You Should Retain Stryker (SYK) Stock For Now
- Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on it.
- 11/25/2022
|
Final Trades: GM, Workday, Stryker & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 11/17/2022
|
Final Trades: Uber, IBM, Stryker & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 11/08/2022
|
2 Under-the-Radar Medtech Stocks to Buy Now
- Don't count out these discounted medical technology stocks.
- 11/05/2022
|
Stryker's (SYK) Q3 Earnings Miss Estimates, Volume Improves
- Stryker's (SYK) third-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurt sales growth.
- 11/01/2022
|
Stryker Corporation (SYK) Q3 2022 Earnings Call Transcript
- Stryker Corporation (NYSE:SYK ) Q3 2022 Earnings Conference Call October 31, 2022 4:30 PM ET Company Participants Kevin Lobo - Chair and Chief Executive Officer Glenn Boehnlein - Chief Financial Officer Jason Beach - Vice President, Investor Relations Conference Call Participants Robert Marcus - JPMorgan Larry Biegelsen - Wells Fargo Vijay Kumar - Evercore ISI Pito Chickering - Deutsche Bank Matthew O'Brien - Piper Sandler Joshua Jennings - Cowen & Co. Matthew Miksic - Barclays Rick Wise - Stifel Drew Ranieri - Morgan Stanley David Saxon - Needham & Company Steven Lichtman - Oppenheimer Ryan Zimmerman - BTIG Matthew Taylor - Jefferies Samuel Brodovsky - Truist Securities Jayson Bedford - Raymond James Jeff Johnson - Baird Operator Welcome to the Third Quarter 2022 Stryker Earnings Call. My name is Megan, and I'll be your operator for today's call.
- 10/31/2022
|
Stryker (SYK) Misses Q3 Earnings Estimates
- Stryker (SYK) delivered earnings and revenue surprises of -5.36% and 0.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 10/31/2022
|
Stryker Corp. stock falls after company lowers outlook for 2022
- Shares of Stryker Corp. SYK, +0.00% fell more than 4% in the extended session Monday after the maker of surgical equipment and other medical devices reported third-quarter results above analyst expectations but lowered its profit outlook for the year, thanks to inflation and a stronger dollar. Striker earned $816 million, or $2.14 a share, in the quarter, compared with $495 million, or $1.14 a share, in the year-earlier period.
- 10/31/2022
|
3 Medical Stocks On the Rebound
- As surgeries bounce back toward pre-pandemic levels, these three companies should benefit.
- 10/26/2022
|
Income Plus Low Volatility Makes This Fund A Safe Haven
- Are you looking for a relatively safe mutual fund haven amid current market carnage? Check out Madison Covered Call & Equity Income Fund (MENYX).
- 10/12/2022
|
2 Healthcare Stocks That Could Help Make You a Fortune
- If given enough time, these two stocks can do the heavy lifting in building wealth for you.
- 10/08/2022
|
Stryker - A Leading MedTech Company Worth A Second Look
- I've been taking long looks at dividend-paying solid companies with relatively low yield, but very high safeties. Stryker is my latest in a long line of this. Stryker is a multinational MedTech business based out of Michigan. They have specific niches in implants, surgical equipment and endoscopy as well as communication systems.
- 10/08/2022
|
Stryker to host conference call on October 31, 2022
- Kalamazoo, Michigan, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Monday, October 31, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending September 30, 2022 and provide an operational update. Final operating results for the quarter will be released at 4:05 p.m. that day.
- 09/29/2022
|
Stryker (SYK) Launches Q Guidance System for Spine Applications
- Stryker's (SYK) Q Guidance System is expected to be a procedural ecosystem for surgeons during guided spine surgery following its launch.
- 09/28/2022
|
Stryker's (SYK) OptaBlate Tumor Ablation System Gets FDA Nod
- Stryker's (SYK) OptaBlate bone tumor ablation system is set to offer a reliable solution for people living with painful metastatic tumors.
- 09/23/2022
|
3 Undervalued Dividend Champions With High Return Potential
- Income investors sometimes take the route of finding the best income stocks to meet their needs based upon criteria like dividend safety, dividend growth potential or historical dividend streak. These can help investors find great dividend champions that will provide them with years of income.
- 09/22/2022
|
Here's Why You Should Retain Stryker (SYK) Stock For Now
- Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure weighs on it.
- 09/21/2022
|
Diamon Hill CEO names a ‘mispriced' medical technology stock
- Stryker Corporation (NYSE: SYK) is a “mispriced” stock that has potential to offer lucrative returns over the long term, says Heather Brilliant. She's the Chief Executive of Diamon Hill Capital Management.
- 09/20/2022
|
There's always an opportunity to find mispriced stocks, says Diamond Hill CEO Heather Brilliant
- Heather Brilliant, Diamond Hill Capital Management president and CEO, joins CNBC's 'Squawk Box' ahead of the open on Tuesday to break down potential investment opportunities.
- 09/20/2022
|
Should You Buy Stryker Stock Around $225?
- Stryker stock (NYSE: SYK), a medical devices company, has seen a 15% fall this year, in line with the broader S&P500 index, down 17%.
- 09/16/2022
|
Why Stryker Remains a Top Health Care Name
- Stryker Corporation ( SYK , Financial) has long been one of my favorite health care names as the company provides some market-leading medical devices.
- 08/25/2022
|
Why This Dividend Stock Is a Buy
- Stryker's medical devices reach more than 100 million patients each year.
- 08/18/2022
|
Should You Really Care About This Company's Short-Term Success?
- Abbott Laboratories' growth looks much less impressive after removing sales from COVID-19 diagnostics.
- 08/05/2022
|
Stryker Is A Moat-Worthy Buy, Here's Why
- Stryker is a diversified medical technology company with strong sales growth, profitability, and a long history of dividend growth. It's well positioned to invest in strategic growth areas and benefits from favorable demographic tailwinds.
- 08/03/2022
|
Stryker Corporation (SYK) CEO Kevin Lobo on Q2 2022 Results - Earnings Call Transcript
- Stryker Corporation (NYSE:SYK ) Q2 2022 Earnings Conference Call July 26, 2022 4:30 PM ET Company Participants Kevin Lobo - Chair and Chief Executive Officer Glenn Boehnlein - Chief Financial Officer Jason Beach - Vice President, Investor Relations Conference Call Participants Robbie Marcus - JPMorgan Lawrence Biegelsen - Wells Fargo Vijay Kumar - Evercore Pito Chickering - Deutsche Bank Matthew O'Brien - Piper Sandler Joanne Wuensch - Citi Joshua Jennings - Cowen Kyle Rose - Canaccord Chris Pasquale - Nephron Research Steve Lichtman - with Oppenheimer Travis Steed - Bank of America Drew Ranieri - Morgan Stanley Michael Matson - Needham & Company Jeff Johnson - Baird Shagun Singh - RBC Ryan Zimmerman - BTIG Operator Welcome to the Second Quarter 2022 Stryker Earnings Call. My name is Hannah and I will be your operator for today's call.
- 07/26/2022
|
Stryker (SYK) Lags Q2 Earnings and Revenue Estimates
- Stryker (SYK) delivered earnings and revenue surprises of -0.88% and 0.78%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 07/26/2022
|
J&J Medtech Outlook Boosts Shares of Stryker, Biomet and Intuitive
- While Johnson & Johnson's ( JNJ , Financial) Medtech sales were lower in the second quarter, revenue from hips and knee replacements was on target or above, a development that could spill over into segment competitors Stryker Corp. ( SYK , Financial) and Zimmer Bioment Holdings Inc. ( ZBH , Financial), as well as robotic surgery leader Intuitive Surgical Inc. ( ISRG , Financial), analysts said in a Fierce Pharma article.
- 07/19/2022
|
Is This Healthcare Stock a Buy for Dividend Growth Investors?
- Medical devices are essential to helping a growing global population live longer and healthier lives.
- 07/14/2022
|
2 Top Healthcare Stocks to Buy Right Now
- Healthcare is a sturdy economic sector. And these two companies are major leaders within their respective industries.
- 07/09/2022
|
Stryker to host conference call on July 26, 2022
- Kalamazoo, Michigan, June 30, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, July 26, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2022 and provide an operational update. Final operating results for the quarter ended June 30, 2022 will be released at 4:05 p.m. that day.
- 06/30/2022
|
Stryker (SYK) to Boost Presence in China Via Digital Healthcare
- Stryker's (SYK) participation at the WIC in China marks a milestone for the company as it can bring more Advanced Digital Healthcare solutions to the China market.
- 06/28/2022
|
Here's Why You Should Hold on to Stryker (SYK) Stock for Now
- Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure weighs on it.
- 06/15/2022
|
5 High-Quality Ray Dalio Stocks Near 52-Week Lows
- According to current portfolio statistics, a Premium feature of GuruFocus, five stocks in Bridgewater Associates' first-quarter 13F equity portfolio that have high business predictability and are trading near 52-week lows are UDR Inc. ( UDR , Financial), HCA Healthcare Inc. ( HCA , Financial), Universal Health Services Inc. ( UHS , Financial), Stryker Corp. ( SYK , Financial) and Amerco Inc. ( UHAL , Financial).
- 06/08/2022
|
3 Disruptive Tech Stocks to Go All In on Now
- Disruptive tech stocks boast unique competitive advantages as well as sticky consumer and global footprints. The post 3 Disruptive Tech Stocks to Go All In on Now appeared first on InvestorPlace.
- 06/06/2022
|
Stryker (SYK) Launches EasyFuse Dynamic Compression System For Foot And Ankle Applications
- Stryker (NYSE: SYK) has announced the launch of its EasyFuse Dynamic Compression System. These are the details.
- 05/25/2022
|
Stryker: Innovation And Acquisition
- Stryker is a Dividend Champion with 28 consecutive years of dividend growth. Shares currently yield 1.20%. Stryker is a leader in the innovative med-tech sector that helps to advance healthcare solutions across a variety of ailments.
- 05/23/2022
|
5 Reasons Why Today's Market Turmoil Shouldn't Shake You
- And it actually may be time to buy.
- 05/21/2022
|
Here's Why You Should Hold on to Stryker (SYK) Stock for Now
- Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure weighs on it.
- 05/16/2022
|
Stryker (SYK) Announces Board Leadership Changes
- Stryker (NYSE: SYK) announced yesterday that the board of directors approved leadership and committee assignment changes. These are the details.
- 05/05/2022
|
Will Stryker Stock See Higher Levels?
- While the company's management expects its full-year sales to rise at the higher end of its guided range of 6% to 8%, it expects its adjusted EPS to be toward the lower end of the guided range of $9.60 to $10.00.
- 05/03/2022
|
Stryker (SYK) Q1 Earnings and Revenues Surpass Estimates
- Stryker's (SYK) first-quarter earnings reflect strong performance across its segments.
- 04/29/2022
|
Stryker Corp (SYK) CEO Kevin Lobo on Q1 2022 Results - Earnings Call Transcript
- Stryker Corp (NYSE:SYK ) Q1 2022 Earnings Conference Call April 28, 2022 4:30 PM ET Company Participants Kevin Lobo - Chairman, CEO & President Preston Wells - VP, IR Glenn Boehnlein - VP & CFO Conference Call Participants Vijay Kumar - Evercore ISI Matthew Miksic - Crédit Suisse Robert Marcus - JPMorgan Chase & Co. Jason Wittes - Loop Capital Markets Danielle Antalffy - SVB Leerink Andrew Stafford - Piper Sandler & Co. David Saxon - Needham & Company Ryan Zimmerman - BTIG Andrew Ranieri - Morgan Stanley Richard Newitter - Truist Joshua Jennings - Cowen and Company Joanne Wuensch - Citigroup Lawrence Biegelsen - Wells Fargo Securities Philip Chickering - Deutsche Bank Operator Welcome to the First Quarter 2022 Stryker's Earnings Conference Call. My name is Brika, and I'll be your operator for today.
- 04/28/2022
|
Stryker (SYK) Q1 Earnings and Revenues Surpass Estimates
- Stryker (SYK) delivered earnings and revenue surprises of 2.07% and 1.79%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 04/28/2022
|
Stryker (SYK) Reports Next Week: What Awaits?
- Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/21/2022
|
The Safest Healthcare Stocks in the World
- Stryker, Johnson & Johnson, and Intuitive Surgical can be counted on to be steady performers in your portfolio.
- 04/18/2022
|
This Medical Devices Company Is Likely To Offer Better Returns Over Medtronic Stock
- We think that Stryker Corp. stock currently is a better pick compared to its industry peer, Medtronic stock, despite it being the more expensive of the two, trading at 5.7x trailing revenues compared to 4.7x for Medtronic. Even if we were to look at the P/EBIT ratio, SYK stock appears to be more.
- 04/11/2022
|
Medical equipment maker Stryker is ‘caught in a margin squeeze,' short-seller says
- Ben Axler, Spruce Point Capital Management Founder and CIO, discusses medical equipment maker Stryker and why the stock is risky.
- 04/09/2022
|
Why Is Stryker (SYK) Stock in the Spotlight Today?
- Perhaps one of the most interesting targets of short sellers recently, SYK stock now has a bearish thesis for investors to consider today. The post Why Is Stryker (SYK) Stock in the Spotlight Today?
- 04/06/2022
|
Short seller: Stryker Corporation shares could crash ‘up to' 75%
- Shares of Stryker Corporation (NYSE: SYK) have recovered 8.0% in about a month – an uptick that investors should use to get out of the stock, suggests Spruce Point in its recent report. Spruce Point sees downside to $67 a share Spruce Point has a “strong sell opinion” on Stryker Corporation.
- 04/06/2022
|
Here's Why You Should Hold on to Stryker (SYK) Stock for Now
- Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure remains a concern.
- 04/05/2022
|
7 Medical Device Stocks to Buy as Covid-19 Fears Fade
- With concerns about Covid-19 fading into the rearview mirror, the normalization of healthcare could benefit these medical device stocks. The post 7 Medical Device Stocks to Buy as Covid-19 Fears Fade appeared first on InvestorPlace.
- 04/05/2022
|
Here's Why This Recently Split Stock Could Soar Again
- This market leader is set for a major earnings rebound.
- 04/04/2022
|
Orthopedics Device Space Gaining Prominence: 3 Stocks in Focus
- Stocks like Orthofix Medical Inc. (OFIX), Stryker Corporation (SYK) and NuVasive, Inc. (NUVA) are likely to gain enormously from developments in the orthopedic space.
- 03/31/2022
|
Stryker to host conference call on April 28, 2022
- Kalamazoo, Michigan, March 30, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, April 28, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2022 and provide an operational update.Final operating results for the quarter ended March 31, 2022 will be released at 4:05 p.m. that day.
- 03/30/2022
|
3 Top Stocks to Buy In a Market Pullback
- These three stocks from diverse industries make great investments during a market correction.
- 03/29/2022
|
Upcoming Ex-Dividend Dates: March 16-31, 2022
- We provide a summary of upcoming ex-dividend dates in a quick reference table.
- 03/15/2022
|
Here's Why You Should Hold on to Stryker (SYK) Stock for Now
- Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure remains a concern.
- 03/07/2022
|
4 Stocks in Spotlight With AI Making Inroads in MedTech
- MedTech stocks like Medtronic (MDT), Stryker (SYK), Allscripts Healthcare Solutions (MDRX) and Syneos Health (SYNH) are evolving rapidly in the field of AI-driven technologies.
- 03/07/2022
|
IHI: A Standout Performer With Equally Strong Future Growth Prospects
- IHI: A Standout Performer With Equally Strong Future Growth Prospects
- 03/05/2022
|
3 Healthcare Stocks That Could Set You Up for Life
- Each of these stocks dominates their industry within the healthcare sector.
- 02/26/2022
|
DEF: Definitely Don't Buy Into This Defensive ETF
- DEF: Definitely Don't Buy Into This Defensive ETF
- 02/22/2022
|
Riding The Stock Waves: Update On The Medical Devices Sector
- Riding The Stock Waves: Update On The Medical Devices Sector
- 02/21/2022
|
BAX vs. SYK: Which Stock Should Value Investors Buy Now?
- BAX vs. SYK: Which Stock Is the Better Value Option?
- 02/15/2022
|
10 Health Care Stocks Warren Buffett Owns That Offer Safety and Dependable Dividends
- If any investor has stood the test of time, it is Warren Buffett, and with good reason.
- 02/14/2022
|
The Vanguard Health Care Fund's Top 5 Trades
- The Vanguard Health Care Fund (Trades, Portfolio) released its fourth-quarter 2021 portfolio earlier this week.
- 02/10/2022
|
Final Trades: Qualcomm, CVS, Nvidia & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 02/02/2022
|
Cramer says the problems weighing on medical device stocks are temporary, expects a bounce back
- "Mad Money" host Jim Cramer explained Tuesday why he expects to see a bounce back in shares of Edwards Lifesciences, Intuitive Surgical and Stryker.
- 02/01/2022
|
Jim Cramer says these three medical device stocks look like 'true steals' here
- "I think there are some true steals are developing in the medical device space because of omicron," the "Mad Money" host said.
- 02/01/2022
|
Stryker (SYK) Q4 Earnings Miss Estimates, Revenues Beat
- Despite pandemic-led disruptions, Stryker's (SYK) fourth-quarter earnings reflect strong performance across its segments.
- 01/28/2022
|
Stryker Posts Mixed Bag Q4 Earnings, Issues FY22 Guidance Below Consensus
- Stryker Corp (NYSE: SYK) posted Q4 adjusted EPS of $2.71, down 3.6% Y/Y, missing the consensus of $2.72. "We delivered a strong year of financial results, despite the ongoing challenges of the pandemic," said Kevin Lobo, Chair & CEO.
- 01/28/2022
|
Stryker Corporation (SYK) CEO Kevin Lobo on Q4 2021 Results - Earnings Call Transcript
- Stryker Corporation (SYK) CEO Kevin Lobo on Q4 2021 Results - Earnings Call Transcript
- 01/27/2022
|
Stryker (SYK) Q4 Earnings Lag Estimates
- Stryker (SYK) delivered earnings and revenue surprises of -0.37% and 1.93%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 01/27/2022
|
Stryker: COVID Delays And Digital Communications
- Up to ~30% of Stryker's customers have elective issues; however, the underlying diseases are progressive so they delay rather than stop acquiring Stryker's products. COVID notwithstanding, Stryker remains in a strong financial position.
- 01/23/2022
|
Stryker (SYK) to Boost Digital Capabilities With New Buyout
- Stryker (SYK) inks a deal with Vocera to enhance its digital healthcare offerings.
- 01/07/2022
|
Vocera (VCRA) to be Acquired by Stryker for $79.25 Per Share
- The Vocera (VCRA) acquisition will help Stryker accelerate its digital goals to improve the lives of caregivers and patients.
- 01/07/2022
|
Why Stryker (SYK) Is Buying Vocera Communications (VCRA) For About $3.09 Billion
- Stryker (NYSE: SYK) announced it is buying Vocera Communications, Inc. (NYSE: VCRA) for approximately $3.09 billion. These are the details.
- 01/06/2022
|
Vocera Communications up 25% after entering a definitive agreement with Stryker
- Vocera Communications Inc. (NYSE: VCRA) went up by 25% after it was announced that it was entering a definitive merger agreement with Stryker (NYSE: SYK) whereby Stryker would acquire its outstanding common stock shares for $79.25 per share. As a result, the total equity value will come to roughly $2.97 billion.
- 01/06/2022
|
Here's Why You Should Retain Stryker (SYK) Stock Right Now
- Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure remains a concern.
- 01/06/2022
|
VCRA Stock: 8 Things for Vocera Investors to Know About the Stryker Deal as Shares Soar
- Vocera Communications (VCRA) stock is on the move Thursday as investors react to news of Stryker (SYK) acquiring the company. The post VCRA Stock: 8 Things for Vocera Investors to Know About the Stryker Deal as Shares Soar appeared first on InvestorPlace.
- 01/06/2022
|
Microbot Medical's Stryker Collaboration Makes This An Intriguing High Flier
- Microbot Medical's Stryker Collaboration Makes This An Intriguing High Flier
- 01/06/2022
|
Stryker to host conference call on January 27, 2022
- Kalamazoo, Michigan, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, January 27, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended December 31, 2021 and provide an operational update. Final operating results for the quarter ended December 31, 2021 will be released at 4:05 p.m. that day.
- 01/05/2022
|
Upcoming Ex-Dividend Dates: December 30-January 7, 2022
- We provide a summary of upcoming ex-dividend dates in a quick reference table.
- 12/30/2021
|
Oppenheimer healthcare strategist on why he likes the CRO space in 2022
- Jared Holz, Oppenheimer healthcare strategist, joins 'Power Lunch' to discuss the healthcare sector and why biotech companies could struggle the most in the space. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC Turn to CNBC TV for the latest stock market news and analysis.
- 12/28/2021
|
Microbot's stock rockets on heavy volume after collaboration pact with Stryker on robotic procedural kits
- Shares of Microbot Medical Inc. MBOT, +7.11% rocketed 67.3% toward a nine-month high on heavy volume in premarket trading Monday, after the pre-clinical medical device company announced an agreement with Stryker Corp. SYK, +1.59% to develop the first dedicated robotic procedural kits for use in certain neurovascular procedures. Trading volume ballooned to 9.6 million shares, compared with the full-day average of about 49,000 shares.
- 12/27/2021
|
20 Dividend Increases To Finish 2021
- All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 9.0% and a median increase of 5.4%. I've tracked 524 increases in 2021.
- 12/23/2021
|
Stryker Stock (SYK): $305 Price Target From Loop Capital
- The shares of Stryker Corporation (NYSE: SYK) have received a $305 price target from Loop Capital. These are the details.
- 12/12/2021
|
2 Healthcare Stocks Delivering Double-Digit Dividend Increases
- The healthcare sector is often one of the most recession-resistant areas of the market given that its products and services remain in demand even as the economy enters a downturn. People value their health as this impacts their quality of life, allowing companies in the healthcare sector to see rather consistent results throughout the economic cycle.
- 12/10/2021
|
Stryker raises dividend by 10%, to lift implied yield above 1%
- Stryker Corp. SYK, +0.28% said Thursday it will raise its quarterly dividend by 10.3%, to 69.5 cents a share from 63 cents. The medical technology company's new dividend will be payable Jan. 31 to shareholders of record on Dec. 31.
- 12/09/2021
|
5 ‘Strong Buy' Blue Chip Stocks With Dividend Hikes Expected This Week
- After years of a low interest rate environment, many investors have turned to equities not only for the growth potential but also for solid and dependable dividends, which help to provide an income stream.
- 12/06/2021
|
5 Buy-Rated Blue Chip Stocks With Dividends Expected to Rise This Week
- After years of a low interest rate environment, many investors have turned to equities not only for the growth potential but also for solid and dependable dividends, which help to provide an income stream.
- 11/29/2021
|
AHCO vs. SYK: Which Stock Should Value Investors Buy Now?
- AHCO vs. SYK: Which Stock Is the Better Value Option?
- 11/22/2021
|
Stryker: A Q3 Earnings Hiccup In A Broader Bullish Trend
- Stryker: A Q3 Earnings Hiccup In A Broader Bullish Trend
- 11/01/2021
|
Stryker (SYK) Earnings and Revenues Miss Estimates in Q3
- Despite pandemic-led disruptions, Stryker's (SYK) third-quarter earnings reflect strong performance across Orthopaedics, MedSurg and Neurotechnology and Spine segments.
- 10/29/2021
|
Stryker Corporation (SYK) CEO Kevin Lobo on Q3 2021 Results - Earnings Call Transcript
- Stryker Corporation (SYK) CEO Kevin Lobo on Q3 2021 Results - Earnings Call Transcript
- 10/28/2021
|
Stryker (SYK) Q3 Earnings and Revenues Lag Estimates
- Stryker (SYK) delivered earnings and revenue surprises of -3.51% and -1.91%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 10/28/2021
|
Stryker (SYK) to Report Q3 Earnings: What's in the Cards?
- Stryker's (SYK) third-quarter results are likely to reflect strong segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.
- 10/22/2021
|
Why Stryker Is A Gift For Growth Investors
- Why Stryker Is A Gift For Growth Investors
- 10/20/2021
|
2 Top Healthcare Stocks to Buy for the Long Haul
- These two blue-chip healthcare stocks can help long-term investors sleep well at night.
- 10/13/2021
|
Stryker to host analyst meeting
- Kalamazoo, Michigan, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host an Analyst Meeting on Thursday, November 18, 2021, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey.
- 10/11/2021
|
This Stock Is Likely To Outperform Boston Scientific
- We think that Stryker stock (NYSE: SYK) currently is a better pick compared to Boston Scientific stock, despite Stryker being slightly more expensive of the two. Stryker trades at about 6.4x trailing revenues, compared to 5.7x for Boston Scientific.
- 10/07/2021
|
Upcoming Ex-Dividend Dates: September 28-October 11, 2021
- Upcoming Ex-Dividend Dates: September 28-October 11, 2021
- 09/27/2021
|
4 Stocks to Watch as Demand for Surgical Robots Ready to Rise
- Watch out for the likes of Asensus Surgical (ASXC), Stryker (SYK), Medtronic (MDT) and Intuitive Surgical (ISRG) as demand for surgical robots is set to rise, owing to the conveniences they offer.
- 09/24/2021
|
Stryker to host conference call on October 28, 2021
- Kalamazoo, Michigan, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, October 28, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2021 and provide an operational update. Final operating results for the quarter ended September 30, 2021 will be released at 4:05 p.m. that day.
- 09/23/2021
|
5 Stocks to Deflect Delta Variant Curveball From Orthopedic Space
- OrthoPediatrics (KIDS), Orthofix (OFIX), Zimmer Biomet (ZBH), Stryker (SYK) and SeaSpine (SPNE) are expected to hold ground despite a challenging business climate.
- 09/23/2021
|
Upcoming Ex-Dividend Dates: September 21-October 4, 2021
- We provide a summary of upcoming ex-dividend dates in a quick reference table. The table includes relevant data and key statistics as well as the next payout and pay date.
- 09/19/2021
|
Stryker's (SYK) Trauma & Extremities Arm Unveils New Product
- The newly launched Citrelock Tendon Fixation Device System expands Stryker's (SYK) Foot & Ankle offerings.
- 09/17/2021
|
Stryker Corp: A Health Care Company You Shouldn't Ignore
- Medical device companies are gradually seeing a rebound in their business as fewer elective medical visits, procedures and surgeries are being delayed due to Covid-19.
- 09/14/2021
|
Final Trades: Stryker, Editas Medicine, Oracle & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 09/13/2021
|
Stryker (SYK) Hits New 52-Week High: What's Driving It?
- Investors are optimistic about Stryker's (SYK) strength in robotics and its diversified product portfolio.
- 09/09/2021
|
Stryker Acquires Provider Of Blood Loss Monitoring Platform
- Stryker Corporation (NYSE: SYK) has acquired Gauss Surgical for an undisclosed consideration. Gauss Surgical is a medical device company that has developed Triton, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery.
- 09/08/2021
|
Here's Why You Should Retain Stryker (SYK) Stock Right Now
- Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure raises a concern.
- 09/02/2021
|
Stuart F. Simpson is THINK Surgical's New President and Chief Executive Officer
- FREMONT, Calif., Sept. 1, 2021 /PRNewswire/ -- THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced the appointment of Stuart F.
- 09/01/2021
|
Stryker to participate in Morgan Stanley's 19th Annual Global Healthcare Conference
- Kalamazoo, Michigan, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in Morgan Stanley's 19th Annual Global Healthcare Conference on Monday, September 13, 2021.
- 08/30/2021
|
This Revolutionary Medical Device Company Goes to 11
- To stand tall against a competitive market, NuVasive depends on a strong spinal platform.
- 08/13/2021
|
The Highest Quality Dividend Growth Stocks
- This article updates one published by David Van Knapp in June 2020.
- 08/03/2021
|
Why Stryker (SYK) is a Top Growth Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 07/29/2021
|
Stryker Corporation's (SYK) CEO Kevin Lobo on Q2 2021 Results - Earnings Call Transcript
- Stryker Corporation's (SYK) CEO Kevin Lobo on Q2 2021 Results - Earnings Call Transcript
- 07/27/2021
|
Stryker (SYK) Q2 Earnings and Revenues Beat Estimates
- Stryker (SYK) delivered earnings and revenue surprises of 6.13% and 4.08%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 07/27/2021
|
FDA OK's Stryker's Implantable, Biodegradable Balloon Spacer For Shoulder Injury
- More than a decade after receiving European CE mark approval, an implantable balloon spacer, InSpace, recently acquired by Stryker Corp (NYSE:SYK), will make its U.S. debut after FDA approval. The InSpace device is placed in the subacromial space of the shoulder to help heal a torn rotator cuff.
- 07/13/2021
|
PHG or SYK: Which Is the Better Value Stock Right Now?
- PHG vs. SYK: Which Stock Is the Better Value Option?
- 07/05/2021
|
Upcoming Ex-Dividend Dates: June 29-July 12, 2021
- This article series presents upcoming ex-dividend dates. We provide a summary table with relevant data and key statistics, including the next payout and pay date.
- 06/27/2021
|
Stryker to host conference call on July 27, 2021
- Kalamazoo, Michigan, June 24, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, July 27, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2021 and provide an operational update. Final operating results for the quarter ended June 30, 2021 will be released at 4:05 p.m. that day.
- 06/24/2021
|
Here's Why You Should Retain Stryker (SYK) Stock Right Now
- Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises a concern.
- 06/23/2021
|
Upcoming Ex-Dividend Dates: June 22-July 5, 2021
- We provide a summary of upcoming ex-dividend dates in a quick reference table. The table includes relevant data and key statistics as well as the next payout and pay date.
- 06/21/2021
|
What Jim Cramer Likes About Roblox, Stryker and More
- The broad markets tipped lower at the close on Wednesday. The one sector that had a solid move was health care, with an emphasis on drug manufacturers.
- 06/10/2021
|
PAHC vs. SYK: Which Stock Is the Better Value Option?
- PAHC vs. SYK: Which Stock Is the Better Value Option?
- 06/07/2021
|
This Part of the Reopening Trade Is Just Getting Started
- As hospitals address the major backlog of pandemic-postponed elective surgeries, medical device makers -- and their stock prices -- could benefit.
- 06/05/2021
|
Why Stryker Is an Excellent Dividend Growth Stock
- Stryker Corp.'s ( SYK , Financial) business was severely impacted by Covid-19 in 2020 as elective surgical procedures were postponed or canceled as the health care industry dealt with the pandemic. Organic growth rates for the company, which have been historically above that of peers, were down last year.
- 06/04/2021
|
Stryker Corp.: A Market Leader Demands A Premium
- Stryker Corp.: A Market Leader Demands A Premium
- 05/27/2021
|
Boston Scientific, Gap, Molson Coors and More Tuesday Afternoon Analyst Calls
- With the trading day more than halfway over, the markets had dipped after a relatively strong start to the day.
- 05/25/2021
|
If You Want A Fast-Growing SWAN, Then Consider Stryker Corp.
- If You Want A Fast-Growing SWAN, Then Consider Stryker Corp.
- 05/25/2021
|
PAHC vs. SYK: Which Stock Should Value Investors Buy Now?
- PAHC vs. SYK: Which Stock Is the Better Value Option?
- 05/21/2021
|
3 Dividend Stocks for Growth and Total Returns
- You may think dividend investing is all about that yield, but you shouldn't turn a blind eye to growth as well. The post 3 Dividend Stocks for Growth and Total Returns appeared first on InvestorPlace.
- 05/17/2021
|
Stryker declares a $0.63 per share quarterly dividend
- Kalamazoo, MI, May 04, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable July 30, 2021 to shareholders of record at the close of business on June 30, 2021, representing an increase of 9.6% versus the prior year and unchanged from the previous quarter.
- 05/04/2021
|
AHCO vs. SYK: Which Stock Should Value Investors Buy Now?
- AHCO vs. SYK: Which Stock Is the Better Value Option?
- 05/04/2021
|
Innovation Drives Robotic-Assisted Surgery: 5 Stocks to Watch
- Rapid innovation is boosting the robotic surgery space, putting the spotlight on Johnson & Johnson (JNJ), Stryker (SYK), Boston Scientific (BSX), Intuitive Surgical (ISRG) and Asensus Surgical (ASXC).
- 05/03/2021
|
Stryker Corporation's (SYK) CEO Kevin Lobo on Q1 2021 Results - Earnings Call Transcript
- Stryker Corporation's (SYK) CEO Kevin Lobo on Q1 2021 Results - Earnings Call Transcript
- 04/27/2021
|
A Preview Of Stryker's Earnings
- Stryker (NYSE:SYK) unveils its next round of earnings this Tuesday, April 27. Here is Benzinga's everything-that-matters guide for the earnings announcement.
- 04/26/2021
|
Stryker to participate in the Bank of America Securities 2021 Virtual Health Care Conference
- Kalamazoo, Michigan, April 26, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021.
- 04/26/2021
|
Stryker (SYK) to Report Q1 Earnings: What's in the Cards?
- Stryker's (SYK) first-quarter results are likely to reflect strong segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.
- 04/22/2021
|
Here's Why You Should Retain Stryker (SYK) Stock Right Now
- Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako and broad product portfolio. However, pricing pressure raises a concern.
- 04/20/2021
|
This Important Acquisition Is Starting to Pay Off for Stryker
- Mako is primed to "Stryke" in the second half of the year.
- 04/13/2021
|
Stryker to host conference call on April 27, 2021
- Kalamazoo, Michigan, March 29, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, April 27, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2021 and provide an operational update. Final operating results for the quarter ended March 31, 2021 will be released at 4:05 p.m. that day.
- 03/29/2021
|
Upcoming Ex-Dividend Dates: March 30-April 12, 2021
- Upcoming Ex-Dividend Dates: March 30-April 12, 2021
- 03/29/2021
|
Stryker announces Annual Meeting of Shareholders
- Kalamazoo, Michigan, March 24, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2021 Annual Meeting of Shareholders is scheduled as follows:
- 03/24/2021
|
Here's Why You Should Retain Stryker (SYK) Stock Right Now
- Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.
- 03/16/2021
|
Stryker's STAR Ankle Replacement Device Gets FDA Safety Advisory
- The FDA issued a safety advisory on Stryker Corporation's (NYSE: SYK) Scandinavian Total Ankle Replacement devices, also known as STAR Ankle, citing the risk of a plastic component breaking after surgical implantation. According to the FDA, the plastic component may break as soon as three to four years after the device is inserted, leading to surgery to repair or replace the device.
- 03/16/2021
|
Stryker Corp (SYK) Presents at Cowen Healthcare Broker Conference Call - (Transcript)
- Stryker Corp (SYK) Presents at Cowen Healthcare Broker Conference Call - (Transcript)
- 03/02/2021
|
Stryker to participate in the 41st Annual Cowen Health Care Conference
- Kalamazoo, Michigan, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 41st Annual Cowen Health Care Conference on Tuesday, March 2, 2021.
- 02/17/2021
|
Stryker declares a $0.63 per share quarterly dividend
- Kalamazoo, Michigan, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable April 30, 2021 to shareholders of record at the close of business on March 31, 2021, representing an increase of 9.6% versus the prior year and unchanged from the previous quarter.
- 02/02/2021
|
Stryker Corporation (SYK) CEO Kevin Lobo on Q4 2020 Results - Earnings Call Transcript
- Stryker Corporation (SYK) CEO Kevin Lobo on Q4 2020 Results - Earnings Call Transcript
- 01/27/2021
|
Stryker (SYK) Q4 Earnings Surpass Estimates
- Stryker (SYK) delivered earnings and revenue surprises of 10.20% and -0.99%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 01/27/2021
|
Recap: Stryker Q4 Earnings
- Shares of Stryker (NYSE:SYK) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 12.85% over the past year to $2.81, which beat the estimate of $2.55.
- 01/27/2021
|
Stryker reports 2020 operating results and 2021 outlook
- Kalamazoo, Michigan, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2020 and 2021 outlook:
- 01/27/2021
|
Stryker's Earnings Outlook
- On Wednesday, January 27, Stryker (NYSE:SYK) will release its latest earnings report. Check out Benzinga's preview to understand the implications.
- 01/26/2021
|
Stryker (SYK) to Report Q4 Earnings: What's in the Cards?
- Stryker's (SYK) fourth-quarter results are likely to reflect strong segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.
- 01/22/2021
|
This Medical Device Maker Will Be Well Positioned Post COVID
- The pandemic is only a temporary setback for this diversified global manufacturer of medical devices.
- 01/21/2021
|
5 Robotics Stocks to Watch Amid Rising Shift to Automation
- The robotics sector looks poised for a turnaround given the rapid shift to digitization and automation, making it wise to keep an eye on names like iRobot (IRBT), Ambarella (AMBA) and Stryker (SYK)
- 01/12/2021
|
Stryker (SYK) Buys OrthoSensor to Grow in Sensor Technology
- Stryker's (SYK) acquisition of OrthoSensor will help surgeons with real-time data-driven solutions and improve patient outcomes.
- 01/08/2021
|
Robots Will Rule 2021: 5 Stocks Poised to Benefit
- Robotics stocks are poised to grow in 2021, calling for investment in Trimble (TRMB), Rockwell Automation (ROK), ReWalk Robotics (RWLK), Fanuc Corp (FANUY) and Stryker (SYK).
- 01/05/2021
|
Stryker to host conference call on January 27, 2021
- Kalamazoo, Michigan, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Wednesday, January 27, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended December 31, 2020 and provide an operational update. Final operating results for the quarter ended December 31, 2020 will be released at 4:05 p.m. that day.
- 01/04/2021
|
Stryker Corporation: Waiting On A Pullback
- Stryker Corporation is a Dividend Champion with 27 consecutive years of dividend growth. Shares currently yield 1.03%. Stryker Corporation is poised to benefit from an aging and active population.
- 01/04/2021
|
7 Stocks Warren Buffett Should Consider
- Investors like keeping an eye on the famed investor Buffett. Here are seven more companies that could possibly become Warren Buffett stocks.
- 12/30/2020
|
Dividend Changes: December 19-25, 2020
- Dividend Changes: December 19-25, 2020
- 12/29/2020
|
Here's Why You Should Retain Stryker Stock Right Now
- Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.
- 12/22/2020
|
Stryker: Right Place, Right Time, Right Strategy
- Stryker Corp. (NYSE:SYK) is in the right place with the right portfolio of products and the right strategy to continue its winning streak on Wall Street.
- 12/18/2020
|
Dodge & Cox Boosts Stake in Fox
- Dodge & Cox (Trades, Portfolio) has revealed an addition to its holding in Fox Corp. (NASDAQ:FOXA) according to GuruFocus' Real-Time Picks, a Premium feature.
- 12/11/2020
|
Stryker Corporation (SYK) Presents at Evercore ISI Third Annual HealthCONx Conference - Conference Call Transcript
- Stryker Corporation (SYK) Presents at Evercore ISI Third Annual HealthCONx Conference - Conference Call Transcript
- 12/03/2020
|
Stryker raises dividend by 9.6%
- Stryker Corp. said late Wednesday that its board of directors has declared a quarterly dividend of 63 cents a share, payable Jan. 29 to shareholders of record at the close of business on Dec. 31. That's a 9.6% dividend increase, the medical technology company said.
- 12/02/2020
|
Stryker declares a $0.63 per share quarterly dividend
- Kalamazoo, Michigan, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable January 29, 2021 to shareholders of record at the close of business on December 31, 2020, representing an increase of 9.6% versus the prior year and previous quarter.
- 12/02/2020
|
December Will Bring A Significant Dividend Increases From Medical Companies Abbott, Stryker
- I was optimistic with my dividend growth predictions for the last two weeks of November. Notably, Sysco held their dividend steady and Tyson Foods – from which I had expected a double digit boost – only increased their dividend by 6%.
- 11/30/2020
|
20 Most Diverse Cities in the U.S.
- In this article we take a look at the 20 most diverse cities in the US. Click to skip ahead and jump to the 10 most diverse cities in the US.
- 11/25/2020
|
Stryker announces pricing of $600 million senior notes offering
- Kalamazoo, Michigan, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) (the “Company”) announced today that it has priced an offering of $600 million aggregate principal amount of its 0.600% Notes due 2023 (the “Notes”). Unless previously redeemed pursuant to their terms, the Notes will mature on December 1, 2023. The offering of the Notes is expected to settle on November 23, 2020, subject to the satisfaction of customary closing conditions.
- 11/18/2020
|
Stryker to participate in the 3rd Annual Evercore ISI HealthCONx Virtual Conference
- Kalamazoo, Michigan, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 3rd Annual Evercore ISI HealthCONx Virtual Conference on Thursday, December 3, 2020.
- 11/17/2020
|
Stryker completes acquisition of Wright Medical
- Kalamazoo, Michigan, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that it has completed the previously announced acquisition of Wright Medical Group N.V. (NASDAQ: WMGI), a global medical device company focused on extremities and biologics.
- 11/11/2020
|
Stryker announces intention to complete acquisition of Wright Medical
- Kalamazoo, Michigan, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that it intends to complete the acquisition of Wright Medical Group N.V. (NASDAQ: WMGI) by effectuating the mergers described in the tender offer statement on Schedule TO filed by Stryker B.V., an indirect, wholly owned subsidiary of Stryker, with the U.S. Securities and Exchange Commission on December 13, 2019, as amended.
- 11/10/2020
|
Stryker elects Giovanni Caforio to Board of Directors
- Kalamazoo, Michigan, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that Giovanni Caforio, M.D., Chairman and Chief Executive Officer of Bristol Myers Squibb, has been elected to its Board of Directors, effective December 1, 2020.
- 11/09/2020
|
Stryker announces receipt of all required regulatory approvals for proposed acquisition of Wright Medical
- Kalamazoo, Michigan, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that all required regulatory approvals have been obtained for the previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI) by Stryker B.V., an indirect, wholly owned subsidiary of Stryker. The tender offer is being made pursuant to the purchase agreement, dated November 4, 2019, among Stryker, Stryker B.V. and Wright Medical.
- 11/04/2020
|
Final Trades: Honeywell, Stryker, & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 11/02/2020
|
Stryker Corporation (SYK) CEO Kevin Lobo on Q3 2020 Results - Earnings Call Transcript
- Stryker Corporation (SYK) CEO Kevin Lobo on Q3 2020 Results - Earnings Call Transcript
- 10/29/2020
|
Recap: Stryker Q3 Earnings
- Shares of Stryker (NYSE:SYK) decreased 1.75% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 12.04% year over year to $2.14, which beat the estimate of $1.40.
- 10/29/2020
|
Stryker reports third quarter 2020 operating results
- Kalamazoo, Michigan, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2020:
- 10/29/2020
|
